Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 176 publications
18F-Fluciclovine or 68Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial.
Journal: Radiology
Published: June 30, 2026
Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177-PSMA-617.
Journal: The oncologist
Published: June 01, 2026
18F-fluciclovine PET Imaging of Non-PSMA Expressing High-risk Primary Prostate Cancer.
Journal: Clinical nuclear medicine
Published: May 13, 2026
Response to the Comment on "Negative 18 F-FES PET/CT Despite Estrogen Receptor Positivity By Immunohistochemistry."
Journal: Clinical nuclear medicine
Published: April 07, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.
Journal: European urology
Published: March 23, 2026
A novel 18 F-labeled brain penetrant PET ligand for imaging poly(ADP-ribose) polymerase-1.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
[ 18 F]Fluoroestradiol Uptake in Benign Nodular Sclerosing Adenosis of the Breast.
Journal: Clinical nuclear medicine
Published: October 13, 2025
Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617.
Journal: Cancer
Published: September 22, 2025
[18F]-Fluciclovine or [68Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial.
Journal: European urology
Published: August 23, 2025
Bladder activity of different PSMA PET radioligands and impact of furosemide.
Journal: American journal of nuclear medicine and molecular imaging
Published: August 17, 2025
MutSeqR: an open source R package for standardized analysis of error-corrected next-generation sequencing data in genetic toxicology.
Journal: Bioinformatics advances
Published: July 23, 2025
Clinical outcomes of lutetium-177-PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancer.
Journal: The oncologist
Published: July 16, 2025
Last Updated: 09/26/2026